• About
  • Subscribe
  • Advertise
  • Contact
Friday, May 23, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Only half of Australian diabetics getting recommended eye checks

by Myles Hume
October 5, 2020
in Local, News, Optometry, Orthoptics Australia, Research
Reading Time: 3 mins read
A A
Prof Mark Gillies says 98% of serious vision loss from diabetes can be prevented. Image: University of Sydney.

Prof Mark Gillies says 98% of serious vision loss from diabetes can be prevented. Image: University of Sydney.

Share on FacebookShare on Twitter

As the KeepSight program hit 100,000 enrolments, a new University of Sydney study has found only half of diabetics are getting the recommended eye checks, putting them at risk of significant vision loss and blindness.

The University of Sydney paper, recently published in Clinical and Experimental Ophthalmology, linked data from the Sax Institute’s 45 and Up study with Medicare benefits data to examine how frequently almost 25,000 people in New South Wales with diabetes had eye examinations.

The researchers found people with diabetes for 10 or more years were even less likely to get regular eye checks, with almost 80% not having the annual recommended check.

Co-author and ophthalmologist Professor Mark Gillies, from the University of Sydney Faculty of Medicine and Health and Save Sight Institute, said the findings reinforced the need for more education.

“Ninety-eight per cent of serious vision loss from diabetes can be prevented with regular eye examinations and early treatment,” he said.

“I encourage people to use services like KeepSight to keep on top of their appointments. It’s also important they understand the kind of eye check required, as only eye checks that include dilation of the pupil with eye drops (fundus dilation) is appropriate to detect changes in the eye related to diabetes.”

The study findings were revealed in conjunction with Diabetes Australia announcing the KeepSight program had reached 100,000 enrolments.

Greg Johnson.

The program was formally launched to the public in March 2019 and sends reminders to people with diabetes when they are due to have their eyes checked. The initiative, which hopes to replicate outcomes of a similar scheme in the UK, also acts as a national register to identify those having regular exams, as well as the people who aren’t.

Diabetes Australia CEO Professor Greg Johnson said the organisation is confident KeepSight will lead to an increase in people with diabetes accessing eye checks in coming years. Ultimately, he hopes every person with diabetes will attend appointments.

“Having 100,000 Australians with diabetes registered with KeepSight is an important milestone for the program – but there are currently over 1.36 million Australians living with diabetes so we are encouraging every person with diabetes, and all health professionals, to register with KeepSight,” Johnson said.

“The good news is that almost all diabetes-related blindness is preventable if detected and treated early. Diabetes is a complex condition and people with diabetes need to have many regular health checks to manage their condition. It can be time-consuming and sometimes things get overlooked.”

KeepSight is run by Diabetes Australia in partnership with Vision 2020 Australia, Centre for Eye Research Australia and Oculo. It has been co-funded by the Australian Government, Specsavers, Bayer, Novartis and Mylan.

The program has widespread support from leading diabetes and eye health groups including RANZCO, Orthoptics Australia, Optometry Australia, the Australian Diabetes Society and the Australian Diabetes Educators Association.

More reading

KeepSight registrations hit 80,000

Thousands of eyecare providers sign up for KeepSight

Tags: Australian Diabetes Educators AssociationAustralian Diabetes SocietyBayerCentre for Eye Research AustraliadiabetesDiabetes Australiadiabetic eye diseasediabetic retinopathyKeepSightMylanNovartisOculoOptometry AustraliaOrthoptics AustraliaRANZCOSpecsaversVision 2020 Australia

Related Posts

CR Labs' ECO7 lens follows the success of its ECO6 product. Image: CR Labs.

CR Labs launches new sustainable lens in thinner format

by Staff Writer
May 22, 2025

CR Labs has launched ECO7, its latest innovation in sustainable lens technology. The company says the new lens builds on...

The Provincial Referral Hospital of Ratanakiri that has received support from Sight For All. Image: Sight For All.

Sight For All raising funds for ophthalmic equipment in new eye clinics   

by Staff Writer
May 22, 2025

Australian not-for-profit Sight For All has teamed up with long-term supporter ZEISS, in a drive to raise funds for much-needed...

Every year, thousands of Australians receive a life-changing diagnosis of low vision. Image: De Visu/Shutterstock.com.

SeeWay launches national support platform for people with low vision

by Staff Writer
May 21, 2025

SeeWay, an initiative of Guide Dogs NSW/ACT, has launched its holistic support platform for people with permanent low vision. A...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited